Atkore INC Schedule 13G passive stakes

A Schedule 13G filing reveals that American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research collectively hold a 5.3% stake in Atkore Inc.

Vanguard Capital Management has reported beneficial ownership of 5.25% of Atkore Inc.'s common stock as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 2,117,497 shares, representing 6.27% of Atkore Inc.'s common stock as of March 31, 2026.

The Vanguard Group reports 0% beneficial ownership in Atkore Inc. common stock following an internal realignment effective January 12, 2026.

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation jointly reported a beneficial ownership of 3.88% in Atkore Inc. common stock as of September 30, 2025.

BlackRock, Inc. has disclosed a 7.3% beneficial ownership stake in Atkore Inc. common stock, holding 2,462,609 shares as of September 30, 2025.

Gates Capital Management and affiliates report a 7.8% beneficial ownership stake in Atkore Inc., holding 2,628,189 shares.

The Vanguard Group has increased its beneficial ownership in Atkore Inc. to 10.33% of common stock, holding 3,478,248 shares.

The Vanguard Group has filed an amended Schedule 13G, reporting a 9.98% beneficial ownership stake in Atkore Inc.'s common stock.

Gates Capital Management and its affiliates have disclosed a beneficial ownership of 9.5% in Atkore Inc., holding 3,265,061 shares of common stock.

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, reporting a passive 5.00% beneficial ownership stake in Atkore Inc.'s common stock.

Gates Capital Management, L.P. and its affiliates have disclosed a beneficial ownership of 7.5% of Atkore Inc.'s common stock, holding 2,607,354 shares as of December 31, 2024.